More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
The new centre brings advanced corneal procedures pioneered in India
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
This approval confirms the facility's compliance with FDA quality standards and regulatory requirements
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
The patented product, developed by Venus Medicine Research Centre (VMRC) for the treatment of multidrug-resistant (MDR) infections, was sold to Cipla in 2019
Expands bioprocessing footprint across Asia
Subscribe To Our Newsletter & Stay Updated
